DOI QR코드

DOI QR Code

Synthesis and Tautomerism of Novel Quinoxalines (Part I)

새로운 Quinoxaline류의 합성과 토토머화 현상 (제1보)

  • Ho Sik Kim (Department of Chemistry, Catholic University of Daegu) ;
  • Jin Hee Kim (Department of Chemistry, Catholic University of Daegu)
  • 김호식 (대구가톨릭대학교 자연대 화학과) ;
  • 김진희 (대구가톨릭대학교 자연대 화학과)
  • Published : 2003.06.20

Abstract

The reaction of 3-(1-ethoxycarbonyl)ethyl-1,2-dihydro-2-oxoquinoxaline (8) with hydrazine hydrate gave 3-(1-hydrazinocarbonyl)ethyl-2-hydroxyquinoxaline (9). The reaction of compound 9 with substituted benzaldehydes and heteroaryl aldehydes afforded 2-hydroxyquinoxalines (10-12), respectively. The reaction of compound 9 with alkyl (ethoxymethylene)cyanoacetates and ethoxymethylenemalononitrile resulted in the intramolecular cyclization to give the 5-amino-1-[2-(3-hydroxyquinoxalin-2-yl)propanoyl]-pyrazoles (13), respectively. Compounds 10-13 showed the tautomerism between the lactam and lactim forms in dimethyl sulfoxide solution. The tautomer ratios were determined by the $^1H$ NMR. The herbicidal and fungicidal activities of the synthesized compounds were investigated.

3-(1-Ethoxycarbonyl)ethyl-1,2-dihydro-2-oxoquinoxaline(8)을 hydrazine hydrate와 반응시켜 3-(1-hydrazinocarbonyl)ethyl-2-hydroxyquinoxaline(9)을 합성하였고, 화합물 9를 치환 벤즈알데하이드류 또는 heteroaryl aldehyde류와 반응시켜 2-hydroxyquinoxaline류(10-12)를 합성하였다. 또한 화합물 9를 alkyl (ethoxymethylene)- cyanoacetate류 또는 ethoxymethylenemalononitrile과 반응시켜 분자내 고리화반응에 의하여 5-amino-1-[2-(3-hydroxyquinoxalin-2-yl)propanoyl]-pyrazole류(13)를 합성하였다. 얻어진 화합물 10-13은 dimethyl sulfoxide 용액에서 lactam형과 lactime형 사이에 토토머화 현상을 나타내었는데, 이들의 토토머 비를 $^1H$ NMR로서 측정하였다. 그리고 합성한 화합물들에 대한 제초력과 살균력도 조사하였다.

Keywords

References

  1. Cheeseman, C. W. H.; Cookson, R. F. The Chemistry of Heterocyclic Compounds, Condensed Pyrazines; Weissberger, A., Taylor, E. C., Eds.; John Wiley & Sons: New York, 1979; pp 1-290.
  2. Sato, N. ComprehensiveHeterocyclic Chemistry II; Katritzky, A. R.,Rees, C. W., Scriven, E. F., Eds.; Pergamon Press :Oxfod, U. K., 1996; Vol. 6, pp 234-278.
  3. Carta, A.; Sanna, P.; Loriga, M.; Setzu, M. G.; Colla, P. L.; Loddo, R. Farmaco 2002, 57, 19. https://doi.org/10.1016/S0014-827X(01)01153-3
  4. Yanoshita, R.; Okamoto, K.; Yomo, Y; Suwabe, Y.; Oota, A. Japan Kokai Tokkyo Koho JP 0374372
  5. Yanoshita, R.; Okamoto, K.; Yomo, Y; Suwabe, Y.; Oota, A. Chem. Abstr. 1991, 115, 183362e. https://doi.org/10.3987/R-1987-05-1215
  6. Makino, K.; Yoshioka, H. Heterocycles 1987, 26, 1215. https://doi.org/10.1002/jhet.5570260621
  7. Monge, A.; Palop, J. A.; Urbasos. I.; Fernandez-Alvarez,E. J. Heterocyclic Chem. 1989, 26, 1623. https://doi.org/10.1002/jhet.5570260621
  8. Kunes, J.; Spulak M.; Waisser, K.; Slosarek, M.; Janota,J. Pharmazie 2000, 55, 858.
  9. Gao, H.; Yamasaki, E. F.; Chan, K. K.; Shen, L. L.;Snapka, R. M. Cancer Res. 2000, 60, 5937. https://doi.org/10.1002/jhet.5570260442
  10. Kim, H, S.; Kurasawa, Y.; Takada, A. J. HeterocyclicChem. 1989, 26, 1129. https://doi.org/10.1002/jhet.5570330649
  11. Kim, H. S.; Chung, J. Y.; Kim, E. K.; Park, Y. T.; Hong,Y. S.; Lee, M. K.; Kurasawa, Y.; Takada, A. J. HeterocyclicChem. 1996, 33, 1855. https://doi.org/10.1002/jhet.5570340107
  12. Kim, H. S.; Kim, E. K.; Kim, S. S.; Park, Y. T.; Hong,Y. S.; Kurasawa, Y. J. Heterocyclic Chem. 1997, 34, 39. https://doi.org/10.3987/REV-98-SR3
  13. Kim, H. S.; Kurasawa, Y. Heterocycles 1998, 49, 557. https://doi.org/10.1002/jhet.5570370542
  14. Kim, H. S.; Jeong, G.; Lee, H. C.; Kim, J. H.; Park, Y.T.; Okamoto, Y.; Kurasawa, Y. J. Heterocyclic Chem.2000, 37, 1277. https://doi.org/10.1002/jhet.5570370542
  15. Kim, H. S.; Lee, S. U.; Lee, H. C.; Kurasawa, Y. Bull.Korean Chem. Soc. 2002, 23, 511. https://doi.org/10.1021/ja01151a073
  16. L'Italien, Y. J.; Banks, C. K. J. Am. Chem. Soc. 1951,73, 3246. https://doi.org/10.1021/ja01626a082
  17. Gore, P. H.; Hughes, G. K. J. Am. Chem. Soc. 1955, 77,5738. https://doi.org/10.1002/jhet.5570200323
  18. Campaigne, E.; McLaughlin, A. R. J. Heterocycilc Chem.1983, 20, 623. https://doi.org/10.1021/jo01172a014
  19. Fuson, R. C.; Parham, W. E.; Reed, L. J. J. Org. Chem.1946, 11, 194. https://doi.org/10.1021/ja01152a034
  20. Jones, R. G. J. Am. Chem. Soc. 1951, 73, 3684. https://doi.org/10.1021/ja01139a046
  21. Jones, R. G. J. Am. Chem. Soc. 1952, 74, 4889. https://doi.org/10.1021/ja01139a046
  22. Horning, E. C. Organic Syntheses; Parham, W. E.,Reed, L. J., Eds.; John Wiley & Sons: New York, U. S.A., 1995; Collective Vol. 3, pp 395-397. https://doi.org/10.1021/ja00490a046
  23. Bensaude, O.; Chevrier, M.; Dubois, J. E. J. Am. Chem.Soc. 1978, 100, 7055. https://doi.org/10.1021/ja00503a031
  24. Bensaude, O.; Chevrier, M.; Dubois, J. E. J. Am. Chem.Soc. 1979, 101, 2423. https://doi.org/10.1021/ja00503a031
  25. Guillerez, J.; Bensaude, O.; Dubois, J. E. J. Chem. Soc.Perkin Trans. II, 1980, 620.
  26. Sayed, M. A.; El-Khamry, A. A.; Soliman, A. Y.; Afify,A. A.; Kassab, E. A. J. Chem. Soc. Pak. 1988, 10, 315.
  27. Kim, H. S.; Lee, S. U.; Jeong, W. Y.; Han, S. W.; Kim,D. I.; Kurasawa, Y. J. Korean Chem. Soc. 2001, 45, 318.
  28. Kim, H. S.; Jeong, W. Y.; Choi, K. O.; Lee, S. U.; Kwag,S. T.; Lee, M. K. J. Korean Chem. Soc. 2002, 46, 37. https://doi.org/10.5012/jkcs.2002.46.1.037

Cited by

  1. Synthesis of novel quinoxalinone derivatives by conventional and microwave methods and assessing their biological activity vol.34, pp.10, 2011, https://doi.org/10.1007/s12272-011-1004-4
  2. Benzofuroxan으로부터 Quinoxaline 유도체의 합성(제1보) vol.48, pp.4, 2003, https://doi.org/10.5012/jkcs.2004.48.4.385
  3. Benzofuroxan으로부터 Quinoxaline 유도체의 합성(제2보) vol.49, pp.4, 2003, https://doi.org/10.5012/jkcs.2005.49.4.363
  4. Pyrido[2,3-b]pyrazine 유도체의 합성 (제1보) vol.49, pp.6, 2005, https://doi.org/10.5012/jkcs.2005.49.6.617